4.1 Review

COVID-19 vaccines for low- and middle-income countries

Publisher

OXFORD UNIV PRESS
DOI: 10.1093/trstmh/trab045

Keywords

2019 novel coronavirus disease clinical trial; COVID-19; low- and middle-income countries; severe acute respiratory syndrome coronavirus 2; vaccines

Ask authors/readers for more resources

The COVID-19 pandemic poses the biggest threat to public health in a century. While scientists have developed safe and effective vaccines, there is a global disparity in vaccine distribution due to high demand and limited supply. This review highlights the challenges faced by low- and middle-income countries in accessing and distributing COVID-19 vaccines.
The COVID-19 pandemic is the biggest threat to public health in a century. Through hard work and ingenuity, scientists have developed a number of safe and effective vaccines against COVID-19 disease. However, demand far outstrips supply and countries around the world are competing for available vaccines. This review describes how low- and middle-income countries access COVID-19 vaccines, what is being done to distribute vaccines fairly, as well as the challenges ahead.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.1
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available